ALLISON PACHECO: Open Payments
NPI 1144207473 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,844 in 29 payments from 17 companies in 2025. Trend: 2023 $1,595 · 2024 $1,706 · 2025 $1,844
Food & beverage: $1,843Education: $2
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $336 |
| Otsuka America Pharmaceutical, Inc. | 4 | $260 |
| Lilly USA, LLC | 2 | $180 |
| AstraZeneca Pharmaceuticals LP | 3 | $163 |
| Amgen Inc. | 2 | $136 |
| Ardelyx, Inc. | 2 | $130 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| AKEBIA THERAPEUTICS INC | 1 | $111 |
| PFIZER INC. | 1 | $100 |
Products named: Ozempic, MOUNJARO, JYNARQUE, TAVNEOS, Sunosi, AIRSUPRA, BENLYSTA, Vafseo.
Industry payments across GA — which companies pay providers there.
